151 related articles for article (PubMed ID: 5002795)
21. Antimalarial activity of Kelfizina-trimethoprim and Kelfizina-pyrimethamine versus chloroquine in field trials in Nigeria.
Donno L; Sanguineti V; Ricciardi ML; Soldati M
Am J Trop Med Hyg; 1969 Mar; 18(2):182-7. PubMed ID: 4888027
[No Abstract] [Full Text] [Related]
22. A comparative evaluation of sulfalene-trimethoprim and sulphormethoxine-pyrimethamine against falciparum malaria in Thailand.
Chin W; Bear DM; Colwell EJ; Kosakal S
Am J Trop Med Hyg; 1973 May; 22(3):308-12. PubMed ID: 4574753
[No Abstract] [Full Text] [Related]
23. [Treatment of malaria attack with a single injection of sulfadoxine-pyrimethamine].
Depinay A; Holzer L; Felix H
Bull Soc Pathol Exot Filiales; 1972; 65(3):409-17. PubMed ID: 4569978
[No Abstract] [Full Text] [Related]
24. [Trimethoprim-sulfonamide synergism in antibacterial chemotherapy].
Barba C
Recenti Prog Med; 1970 Jun; 48(6):537-55. PubMed ID: 5536683
[No Abstract] [Full Text] [Related]
25. Studies on the chemotherapy of malaria. (III). Treatment of falciparum malaria in the Gambia, with BRL 50216 (4,6-diamino-(3, 4-dichlorobenzyloxy)-1,2-dihydro-2 2-dimethyl-1,3,5-triazine hydrochloride) alone and in combination with sulphonamides,
Laing AB
Trans R Soc Trop Med Hyg; 1974; 68(2):133-8. PubMed ID: 4617937
[No Abstract] [Full Text] [Related]
26. Inhibition of folate biosynthesis and function as a basis for chemotherapy.
Hitchings GH; Burchall JJ
Adv Enzymol Relat Areas Mol Biol; 1965; 27():417-68. PubMed ID: 4387360
[No Abstract] [Full Text] [Related]
27. Trimethoprim: its possible place in antibacterial therapy.
Garrod LP
Drugs; 1971; 1(1):3-6. PubMed ID: 5143138
[No Abstract] [Full Text] [Related]
28. Treatment of Plasmodium falciparum malaria in Cameroon with a single dose of antifolic drugs. 2. Combination of sulfametopyrazine and trimethoprim.
Donno L; Catarinella G
J Trop Med Hyg; 1971 Nov; 74(11):246-8. PubMed ID: 4942347
[No Abstract] [Full Text] [Related]
29. Present trends and future strategy in chemotherapy of malaria.
Chauhan PM; Srivastava SK
Curr Med Chem; 2001 Nov; 8(13):1535-42. PubMed ID: 11562283
[TBL] [Abstract][Full Text] [Related]
30. [Trimethoprim. Folic acid antagonist--synergistic effect with sulphonamides].
Lykkegaard Nielsen M; Laursen H
Nord Med; 1970 Aug; 84(34):1070-3. PubMed ID: 4917032
[No Abstract] [Full Text] [Related]
31. Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis.
Jain V; Yogavel M; Kikuchi H; Oshima Y; Hariguchi N; Matsumoto M; Goel P; Touquet B; Jumani RS; Tacchini-Cottier F; Harlos K; Huston CD; Hakimi MA; Sharma A
Structure; 2017 Oct; 25(10):1495-1505.e6. PubMed ID: 28867614
[TBL] [Abstract][Full Text] [Related]
32. Potentiation of sulfonamides and antibiotics by trimethoprim [2,4-diamino-5-(3,4,5-trimethoxybenzyl) pyrimidine].
Grunberg E; DeLorenzo WF
Antimicrob Agents Chemother (Bethesda); 1966; 6():430-3. PubMed ID: 5985268
[No Abstract] [Full Text] [Related]
33. Why sulphonamides, when combined with 2-4-diamino-pyrimidines, are effective in sulphonamide-resistant gonorrhoea.
Wright DJ
Guys Hosp Rep; 1969; 118(2):287-91. PubMed ID: 5804069
[No Abstract] [Full Text] [Related]
34. Malaria and victory in Vietnam. The first battle against drug-resistant malignant malaria is described.
Modell W
Science; 1968 Dec; 162(3860):1346-52. PubMed ID: 4880851
[No Abstract] [Full Text] [Related]
35. Trimethoprim plus sulphamethoxazole compared with chloroquine in the treatment and suppression of malaria in African schoolchildren.
Fasan PO
Ann Trop Med Parasitol; 1971 Mar; 65(1):117-21. PubMed ID: 4930371
[No Abstract] [Full Text] [Related]
36. [Lymph-node toxoplasmosis: recent clinical, diagnostic and therapeutic acquisitions].
Terragna A
Recenti Prog Med; 1972 Jul; 53(1):79-100. PubMed ID: 4678561
[No Abstract] [Full Text] [Related]
37. Trimethoprim, a sulphonamide potentiator.
Bushby SR; Hitchings GH
Br J Pharmacol Chemother; 1968 May; 33(1):72-90. PubMed ID: 5301731
[No Abstract] [Full Text] [Related]
38. Plasmodium berghei: combining folic acid antagonists for potentiation against malaria infections in mice.
Kinnamon KE; Ager AL; Orchard RW
Exp Parasitol; 1976 Aug; 40(1):95-102. PubMed ID: 780121
[No Abstract] [Full Text] [Related]
39. Pathologic physiology and chemotherapy of Plasmodium berghei. I. Suppression of parasitemia by sulfones and sulfonamides in mice.
Aviado DM
Exp Parasitol; 1967 Feb; 20(1):88-97. PubMed ID: 6026226
[No Abstract] [Full Text] [Related]
40. Resistant malaria.
Br Med J; 1971 Apr; 2(5755):185-6. PubMed ID: 5575949
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
